Standings | Individuals | Scoreboard | Team Detail | Individual Detail | Round Report | Stat Key |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Libo-chan's Busse-ted Wang | 0.5 | 0 | 0 | 10 | 0.00 | 0.00 | 0.00 | 0 | Nguyen et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Rogue Squadron | 1.0 | 3 | 2 | 20 | 1.00 | 0.00 | 1.50 | 20 | Bentley et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Davis et al. | 1.0 | 1 | 1 | 20 | 0.25 | 0.00 | 1.00 | 5 | Raje et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | The Special Relationship | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 |
Total | 6.5 | 7 | 3 | 130 | 0.42 | 0.00 | 2.33 | 55 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Libo-chan's Busse-ted Wang | 1.0 | 6 | 0 | 20 | 3.00 | 0.00 | inf | 60 | Nguyen et al. | 1.0 | 3 | 1 | 20 | 1.25 | 0.00 | 3.00 | 25 | Rogue Squadron | 1.0 | 4 | 2 | 20 | 1.50 | 0.00 | 2.00 | 30 | Bentley et al. | 1.0 | 4 | 1 | 20 | 1.75 | 0.00 | 4.00 | 35 | Davis et al. | 1.0 | 5 | 0 | 20 | 2.50 | 0.00 | inf | 50 | Raje et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | The Special Relationship | 1.0 | 5 | 0 | 20 | 2.50 | 0.00 | inf | 50 |
Total | 7.0 | 29 | 4 | 140 | 1.93 | 0.00 | 7.25 | 270 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Libo-chan's Busse-ted Wang | 1.0 | 3 | 1 | 20 | 1.25 | 0.00 | 3.00 | 25 | Nguyen et al. | 1.0 | 1 | 2 | 20 | 0.00 | 0.00 | 0.50 | 0 | Rogue Squadron | 1.0 | 1 | 2 | 20 | 0.00 | 0.00 | 0.50 | 0 | Bentley et al. | 1.0 | 4 | 0 | 20 | 2.00 | 0.00 | inf | 40 | Davis et al. | 1.0 | 4 | 1 | 20 | 1.75 | 0.00 | 4.00 | 35 | Raje et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | The Special Relationship | 1.0 | 4 | 0 | 20 | 2.00 | 0.00 | inf | 40 |
Total | 7.0 | 18 | 6 | 140 | 1.07 | 0.00 | 3.00 | 150 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Libo-chan's Busse-ted Wang | 1.0 | 1 | 1 | 20 | 0.25 | 0.00 | 1.00 | 5 | Nguyen et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Rogue Squadron | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Bentley et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Davis et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Raje et al. | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 | The Special Relationship | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 |
Total | 7.0 | 11 | 1 | 140 | 0.75 | 0.00 | 11.00 | 105 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Fischer et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Sipp et al. | 1.0 | 1 | 2 | 20 | 0.00 | 0.00 | 0.50 | 0 | Durgin et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Minarik et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Johnston et al. | 1.0 | 5 | 0 | 20 | 2.50 | 0.00 | inf | 50 | Caleb Kendrick is the new Batman | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Berkeley | 1.0 | 2 | 2 | 20 | 0.50 | 0.00 | 1.00 | 10 |
Total | 7.0 | 14 | 4 | 140 | 0.86 | 0.00 | 3.50 | 120 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Fischer et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Sipp et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Durgin et al. | 1.0 | 4 | 0 | 20 | 2.00 | 0.00 | inf | 40 | Minarik et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Johnston et al. | 1.0 | 0 | 1 | 20 | -0.25 | 0.00 | 0.00 | -5 | Caleb Kendrick is the new Batman | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Berkeley | 1.0 | 1 | 1 | 20 | 0.25 | 0.00 | 1.00 | 5 |
Total | 7.0 | 10 | 2 | 140 | 0.64 | 0.00 | 5.00 | 90 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Fischer et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Sipp et al. | 1.0 | 5 | 1 | 20 | 2.25 | 0.00 | 5.00 | 45 | Durgin et al. | 1.0 | 4 | 0 | 20 | 2.00 | 0.00 | inf | 40 | Minarik et al. | 1.0 | 4 | 0 | 20 | 2.00 | 0.00 | inf | 40 | Johnston et al. | 1.0 | 4 | 2 | 20 | 1.50 | 0.00 | 2.00 | 30 | Caleb Kendrick is the new Batman | 1.0 | 3 | 1 | 20 | 1.25 | 0.00 | 3.00 | 25 | Berkeley | 1.0 | 8 | 0 | 20 | 4.00 | 0.00 | inf | 80 |
Total | 7.0 | 30 | 4 | 140 | 2.00 | 0.00 | 7.50 | 280 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Fischer et al. | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 | Sipp et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Durgin et al. | 1.0 | 4 | 0 | 20 | 2.00 | 0.00 | inf | 40 | Minarik et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Johnston et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Caleb Kendrick is the new Batman | 1.0 | 6 | 1 | 20 | 2.75 | 0.00 | 6.00 | 55 | Berkeley | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 |
Total | 7.0 | 18 | 1 | 140 | 1.25 | 0.00 | 18.00 | 175 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Sipp et al. | 1.0 | 5 | 1 | 20 | 2.25 | 0.00 | 5.00 | 45 | Fischer et al. | 1.0 | 2 | 1 | 20 | 0.75 | 0.00 | 2.00 | 15 | Dos Remedios et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Johnston et al. | 1.0 | 3 | 1 | 20 | 1.25 | 0.00 | 3.00 | 25 | Minarik et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Berkeley | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Caleb Kendrick is the new Batman | 1.0 | 5 | 0 | 20 | 2.50 | 0.00 | inf | 50 |
Total | 7.0 | 18 | 3 | 140 | 1.18 | 0.00 | 6.00 | 165 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Sipp et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Fischer et al. | 1.0 | 2 | 1 | 20 | 0.75 | 0.00 | 2.00 | 15 | Dos Remedios et al. | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 | Johnston et al. | 1.0 | 0 | 2 | 20 | -0.50 | 0.00 | 0.00 | -10 | Minarik et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Berkeley | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Caleb Kendrick is the new Batman | 1.0 | 0 | 1 | 20 | -0.25 | 0.00 | 0.00 | -5 |
Total | 7.0 | 7 | 4 | 140 | 0.36 | 0.00 | 1.75 | 50 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Sipp et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Fischer et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Dos Remedios et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Johnston et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Minarik et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Berkeley | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Caleb Kendrick is the new Batman | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 |
Total | 7.0 | 9 | 0 | 140 | 0.64 | 0.00 | inf | 90 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Sipp et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Fischer et al. | 1.0 | 0 | 1 | 20 | -0.25 | 0.00 | 0.00 | -5 | Dos Remedios et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Johnston et al. | 1.0 | 1 | 1 | 20 | 0.25 | 0.00 | 1.00 | 5 | Minarik et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Berkeley | 1.0 | 0 | 1 | 20 | -0.25 | 0.00 | 0.00 | -5 | Caleb Kendrick is the new Batman | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 |
Total | 7.0 | 2 | 3 | 140 | 0.04 | 0.00 | 0.67 | 5 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Dos Remedios et al. | 1.0 | 5 | 1 | 20 | 2.25 | 0.00 | 5.00 | 45 | Sipp et al. | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 | Durgin et al. | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 | Caleb Kendrick is the new Batman | 1.0 | 3 | 1 | 20 | 1.25 | 0.00 | 3.00 | 25 | Berkeley | 1.0 | 2 | 1 | 20 | 0.75 | 0.00 | 2.00 | 15 | Minarik et al. | 1.0 | 2 | 1 | 20 | 0.75 | 0.00 | 2.00 | 15 | Johnston et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 |
Total | 7.0 | 18 | 4 | 140 | 1.14 | 0.00 | 4.50 | 160 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Dos Remedios et al. | 1.0 | 2 | 1 | 20 | 0.75 | 0.00 | 2.00 | 15 | Sipp et al. | 1.0 | 0 | 1 | 20 | -0.25 | 0.00 | 0.00 | -5 | Durgin et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Caleb Kendrick is the new Batman | 1.0 | 1 | 1 | 20 | 0.25 | 0.00 | 1.00 | 5 | Berkeley | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Minarik et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Johnston et al. | 1.0 | 3 | 2 | 20 | 1.00 | 0.00 | 1.50 | 20 |
Total | 7.0 | 10 | 5 | 140 | 0.54 | 0.00 | 2.00 | 75 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Dos Remedios et al. | 1.0 | 5 | 0 | 20 | 2.50 | 0.00 | inf | 50 | Sipp et al. | 1.0 | 7 | 2 | 20 | 3.00 | 0.00 | 3.50 | 60 | Durgin et al. | 1.0 | 11 | 0 | 20 | 5.50 | 0.00 | inf | 110 | Caleb Kendrick is the new Batman | 1.0 | 6 | 1 | 20 | 2.75 | 0.00 | 6.00 | 55 | Berkeley | 1.0 | 9 | 0 | 20 | 4.50 | 0.00 | inf | 90 | Minarik et al. | 1.0 | 5 | 3 | 20 | 1.75 | 0.00 | 1.67 | 35 | Johnston et al. | 1.0 | 4 | 5 | 20 | 0.75 | 0.00 | 0.80 | 15 |
Total | 7.0 | 47 | 11 | 140 | 2.96 | 0.00 | 4.27 | 415 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Dos Remedios et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Sipp et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Durgin et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Caleb Kendrick is the new Batman | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Berkeley | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Minarik et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Johnston et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 |
Total | 7.0 | 2 | 0 | 140 | 0.14 | 0.00 | inf | 20 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Nguyen et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Byrnt Norton | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 | Libo-chan's Busse-ted Wang | 1.0 | 3 | 1 | 20 | 1.25 | 0.00 | 3.00 | 25 | Raje et al. | 1.0 | 3 | 1 | 20 | 1.25 | 0.00 | 3.00 | 25 | The Special Relationship | 1.0 | 3 | 1 | 20 | 1.25 | 0.00 | 3.00 | 25 | Bentley et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Davis et al. | 1.0 | 2 | 1 | 20 | 0.75 | 0.00 | 2.00 | 15 |
Total | 7.0 | 17 | 4 | 140 | 1.07 | 0.00 | 4.25 | 150 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Nguyen et al. | 1.0 | 4 | 2 | 20 | 1.50 | 0.00 | 2.00 | 30 | Byrnt Norton | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Libo-chan's Busse-ted Wang | 1.0 | 2 | 1 | 20 | 0.75 | 0.00 | 2.00 | 15 | Raje et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | The Special Relationship | 1.0 | 1 | 1 | 20 | 0.25 | 0.00 | 1.00 | 5 | Bentley et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Davis et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 |
Total | 7.0 | 12 | 4 | 140 | 0.71 | 0.00 | 3.00 | 100 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Nguyen et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Byrnt Norton | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Libo-chan's Busse-ted Wang | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Raje et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | The Special Relationship | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Bentley et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Davis et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 |
Total | 7.0 | 3 | 0 | 140 | 0.21 | 0.00 | inf | 30 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Nguyen et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Byrnt Norton | 1.0 | 6 | 2 | 20 | 2.50 | 0.00 | 3.00 | 50 | Libo-chan's Busse-ted Wang | 1.0 | 6 | 1 | 20 | 2.75 | 0.00 | 6.00 | 55 | Raje et al. | 1.0 | 1 | 1 | 20 | 0.25 | 0.00 | 1.00 | 5 | The Special Relationship | 1.0 | 2 | 3 | 20 | 0.25 | 0.00 | 0.67 | 5 | Bentley et al. | 1.0 | 8 | 2 | 20 | 3.50 | 0.00 | 4.00 | 70 | Davis et al. | 1.0 | 4 | 0 | 20 | 2.00 | 0.00 | inf | 40 |
Total | 7.0 | 29 | 9 | 140 | 1.75 | 0.00 | 3.22 | 245 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Rogue Squadron | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Byrnt Norton | 1.0 | 4 | 0 | 20 | 2.00 | 0.00 | inf | 40 | Libo-chan's Busse-ted Wang | 1.0 | 4 | 1 | 20 | 1.75 | 0.00 | 4.00 | 35 | Davis et al. | 1.0 | 4 | 1 | 20 | 1.75 | 0.00 | 4.00 | 35 | Bentley et al. | 1.0 | 5 | 0 | 20 | 2.50 | 0.00 | inf | 50 | The Special Relationship | 1.0 | 5 | 1 | 20 | 2.25 | 0.00 | 5.00 | 45 | Raje et al. | 1.0 | 3 | 1 | 20 | 1.25 | 0.00 | 3.00 | 25 |
Total | 7.0 | 27 | 4 | 140 | 1.79 | 0.00 | 6.75 | 250 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Rogue Squadron | 1.0 | 1 | 1 | 20 | 0.25 | 0.00 | 1.00 | 5 | Byrnt Norton | 1.0 | 4 | 1 | 20 | 1.75 | 0.00 | 4.00 | 35 | Libo-chan's Busse-ted Wang | 1.0 | 4 | 1 | 20 | 1.75 | 0.00 | 4.00 | 35 | Davis et al. | 1.0 | 4 | 0 | 20 | 2.00 | 0.00 | inf | 40 | Bentley et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | The Special Relationship | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Raje et al. | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 |
Total | 7.0 | 20 | 3 | 140 | 1.32 | 0.00 | 6.67 | 185 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Rogue Squadron | 1.0 | 5 | 1 | 20 | 2.25 | 0.00 | 5.00 | 45 | Byrnt Norton | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 | Libo-chan's Busse-ted Wang | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 | Davis et al. | 1.0 | 4 | 0 | 20 | 2.00 | 0.00 | inf | 40 | Bentley et al. | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 | The Special Relationship | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 | Raje et al. | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 |
Total | 7.0 | 24 | 1 | 140 | 1.68 | 0.00 | 24.00 | 235 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Rogue Squadron | 1.0 | 3 | 2 | 20 | 1.00 | 0.00 | 1.50 | 20 | Byrnt Norton | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Libo-chan's Busse-ted Wang | 1.0 | 1 | 2 | 20 | 0.00 | 0.00 | 0.50 | 0 | Davis et al. | 1.0 | 0 | 1 | 20 | -0.25 | 0.00 | 0.00 | -5 | Bentley et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | The Special Relationship | 1.0 | 1 | 1 | 20 | 0.25 | 0.00 | 1.00 | 5 | Raje et al. | 1.0 | 2 | 1 | 20 | 0.75 | 0.00 | 2.00 | 15 |
Total | 7.0 | 11 | 7 | 140 | 0.54 | 0.00 | 1.57 | 75 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Durgin et al. | 1.0 | 3 | 2 | 20 | 1.00 | 0.00 | 1.50 | 20 | Fischer et al. | 1.0 | 1 | 1 | 20 | 0.25 | 0.00 | 1.00 | 5 | Dos Remedios et al. | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 | Berkeley | 1.0 | 2 | 3 | 20 | 0.25 | 0.00 | 0.67 | 5 | Caleb Kendrick is the new Batman | 1.0 | 1 | 1 | 20 | 0.25 | 0.00 | 1.00 | 5 | Johnston et al. | 1.0 | 2 | 3 | 20 | 0.25 | 0.00 | 0.67 | 5 | Minarik et al. | 1.0 | 4 | 2 | 20 | 1.50 | 0.00 | 2.00 | 30 |
Total | 7.0 | 16 | 12 | 140 | 0.71 | 0.00 | 1.33 | 100 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Berkeley | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Caleb Kendrick is the new Batman | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 | Johnston et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Minarik et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 |
Total | 4.0 | 4 | 0 | 80 | 0.50 | 0.00 | inf | 40 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Fischer et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Dos Remedios et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Berkeley | 1.0 | 7 | 1 | 20 | 3.25 | 0.00 | 7.00 | 65 | Caleb Kendrick is the new Batman | 1.0 | 8 | 0 | 20 | 4.00 | 0.00 | inf | 80 | Johnston et al. | 1.0 | 5 | 0 | 20 | 2.50 | 0.00 | inf | 50 | Minarik et al. | 1.0 | 3 | 1 | 20 | 1.25 | 0.00 | 3.00 | 25 |
Total | 6.0 | 24 | 2 | 120 | 1.92 | 0.00 | 12.00 | 230 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Byrnt Norton | 1.0 | 2 | 1 | 20 | 0.75 | 0.00 | 2.00 | 15 | Rogue Squadron | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 | Nguyen et al. | 1.0 | 2 | 1 | 20 | 0.75 | 0.00 | 2.00 | 15 | The Special Relationship | 1.0 | 4 | 0 | 20 | 2.00 | 0.00 | inf | 40 | Raje et al. | 1.0 | 1 | 1 | 20 | 0.25 | 0.00 | 1.00 | 5 | Davis et al. | 1.0 | 7 | 0 | 20 | 3.50 | 0.00 | inf | 70 | Bentley et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 |
Total | 7.0 | 20 | 3 | 140 | 1.32 | 0.00 | 6.67 | 185 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Byrnt Norton | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 | Rogue Squadron | 1.0 | 4 | 1 | 20 | 1.75 | 0.00 | 4.00 | 35 | Nguyen et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | The Special Relationship | 1.0 | 1 | 2 | 20 | 0.00 | 0.00 | 0.50 | 0 | Raje et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Davis et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Bentley et al. | 1.0 | 0 | 1 | 20 | -0.25 | 0.00 | 0.00 | -5 |
Total | 7.0 | 13 | 4 | 140 | 0.79 | 0.00 | 3.25 | 110 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Byrnt Norton | 1.0 | 4 | 0 | 20 | 2.00 | 0.00 | inf | 40 | Rogue Squadron | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Nguyen et al. | 1.0 | 4 | 1 | 20 | 1.75 | 0.00 | 4.00 | 35 | The Special Relationship | 1.0 | 4 | 1 | 20 | 1.75 | 0.00 | 4.00 | 35 | Raje et al. | 1.0 | 4 | 0 | 20 | 2.00 | 0.00 | inf | 40 | Davis et al. | 1.0 | 4 | 4 | 20 | 1.00 | 0.00 | 1.00 | 20 | Bentley et al. | 1.0 | 3 | 1 | 20 | 1.25 | 0.00 | 3.00 | 25 |
Total | 7.0 | 25 | 7 | 140 | 1.54 | 0.00 | 3.57 | 215 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Raje et al. | 1.0 | 2 | 3 | 20 | 0.25 | 0.00 | 0.67 | 5 | The Special Relationship | 1.0 | 5 | 2 | 20 | 2.00 | 0.00 | 2.50 | 40 | Davis et al. | 1.0 | 6 | 0 | 20 | 3.00 | 0.00 | inf | 60 | Byrnt Norton | 1.0 | 5 | 0 | 20 | 2.50 | 0.00 | inf | 50 | Nguyen et al. | 1.0 | 7 | 1 | 20 | 3.25 | 0.00 | 7.00 | 65 | Rogue Squadron | 1.0 | 2 | 1 | 20 | 0.75 | 0.00 | 2.00 | 15 | Libo-chan's Busse-ted Wang | 1.0 | 7 | 1 | 20 | 3.25 | 0.00 | 7.00 | 65 |
Total | 7.0 | 34 | 8 | 140 | 2.14 | 0.00 | 4.25 | 300 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Raje et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | The Special Relationship | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Davis et al. | 1.0 | 3 | 1 | 20 | 1.25 | 0.00 | 3.00 | 25 | Byrnt Norton | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Nguyen et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Rogue Squadron | 1.0 | 4 | 0 | 20 | 2.00 | 0.00 | inf | 40 | Libo-chan's Busse-ted Wang | 1.0 | 5 | 0 | 20 | 2.50 | 0.00 | inf | 50 |
Total | 7.0 | 18 | 1 | 140 | 1.25 | 0.00 | 18.00 | 175 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Raje et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | The Special Relationship | 1.0 | 2 | 1 | 20 | 0.75 | 0.00 | 2.00 | 15 | Davis et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Byrnt Norton | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Nguyen et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Rogue Squadron | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Libo-chan's Busse-ted Wang | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 |
Total | 7.0 | 10 | 1 | 140 | 0.68 | 0.00 | 10.00 | 95 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Raje et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | The Special Relationship | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Davis et al. | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 | Byrnt Norton | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Nguyen et al. | 1.0 | 0 | 1 | 20 | -0.25 | 0.00 | 0.00 | -5 | Rogue Squadron | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Libo-chan's Busse-ted Wang | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 |
Total | 7.0 | 6 | 1 | 140 | 0.39 | 0.00 | 6.00 | 55 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Raje et al. | 1.0 | 6 | 1 | 20 | 2.75 | 0.00 | 6.00 | 55 | The Special Relationship | 1.0 | 9 | 0 | 20 | 4.50 | 0.00 | inf | 90 | Bentley et al. | 1.0 | 3 | 3 | 20 | 0.75 | 0.00 | 1.00 | 15 | Nguyen et al. | 1.0 | 8 | 1 | 20 | 3.75 | 0.00 | 8.00 | 75 | Byrnt Norton | 1.0 | 7 | 3 | 20 | 2.75 | 0.00 | 2.33 | 55 | Libo-chan's Busse-ted Wang | 1.0 | 5 | 2 | 20 | 2.00 | 0.00 | 2.50 | 40 | Rogue Squadron | 1.0 | 9 | 2 | 20 | 4.00 | 0.00 | 4.50 | 80 |
Total | 7.0 | 47 | 12 | 140 | 2.93 | 0.00 | 3.92 | 410 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Raje et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | The Special Relationship | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Bentley et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Nguyen et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Byrnt Norton | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Libo-chan's Busse-ted Wang | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Rogue Squadron | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 |
Total | 7.0 | 2 | 0 | 140 | 0.14 | 0.00 | inf | 20 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Raje et al. | 1.0 | 2 | 2 | 20 | 0.50 | 0.00 | 1.00 | 10 | The Special Relationship | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Bentley et al. | 1.0 | 2 | 1 | 20 | 0.75 | 0.00 | 2.00 | 15 | Nguyen et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Byrnt Norton | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Libo-chan's Busse-ted Wang | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Rogue Squadron | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 |
Total | 7.0 | 6 | 3 | 140 | 0.32 | 0.00 | 2.00 | 45 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Libo-chan's Busse-ted Wang | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Rogue Squadron | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 |
Total | 2.0 | 2 | 0 | 40 | 0.50 | 0.00 | inf | 20 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Bentley et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Raje et al. | 1.0 | 5 | 0 | 20 | 2.50 | 0.00 | inf | 50 | Davis et al. | 1.0 | 2 | 1 | 20 | 0.75 | 0.00 | 2.00 | 15 | Libo-chan's Busse-ted Wang | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Rogue Squadron | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Nguyen et al. | 1.0 | 2 | 1 | 20 | 0.75 | 0.00 | 2.00 | 15 | Byrnt Norton | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 |
Total | 7.0 | 16 | 2 | 140 | 1.07 | 0.00 | 8.00 | 150 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Bentley et al. | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 | Raje et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Davis et al. | 1.0 | 0 | 1 | 20 | -0.25 | 0.00 | 0.00 | -5 | Libo-chan's Busse-ted Wang | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Rogue Squadron | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Nguyen et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Byrnt Norton | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 |
Total | 7.0 | 6 | 1 | 140 | 0.39 | 0.00 | 6.00 | 55 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Bentley et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Raje et al. | 1.0 | 2 | 1 | 20 | 0.75 | 0.00 | 2.00 | 15 | Davis et al. | 1.0 | 0 | 1 | 20 | -0.25 | 0.00 | 0.00 | -5 | Libo-chan's Busse-ted Wang | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 | Rogue Squadron | 1.0 | 4 | 0 | 20 | 2.00 | 0.00 | inf | 40 | Nguyen et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Byrnt Norton | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 |
Total | 7.0 | 11 | 2 | 140 | 0.71 | 0.00 | 5.50 | 100 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Bentley et al. | 1.0 | 4 | 2 | 20 | 1.50 | 0.00 | 2.00 | 30 | Raje et al. | 1.0 | 4 | 3 | 20 | 1.25 | 0.00 | 1.33 | 25 | Davis et al. | 1.0 | 8 | 6 | 20 | 2.50 | 0.00 | 1.33 | 50 | Libo-chan's Busse-ted Wang | 1.0 | 7 | 2 | 20 | 3.00 | 0.00 | 3.50 | 60 | Rogue Squadron | 1.0 | 8 | 0 | 20 | 4.00 | 0.00 | inf | 80 | Nguyen et al. | 1.0 | 5 | 2 | 20 | 2.00 | 0.00 | 2.50 | 40 | Byrnt Norton | 1.0 | 3 | 1 | 20 | 1.25 | 0.00 | 3.00 | 25 |
Total | 7.0 | 39 | 16 | 140 | 2.21 | 0.00 | 2.44 | 310 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Minarik et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Berkeley | 1.0 | 0 | 2 | 20 | -0.50 | 0.00 | 0.00 | -10 | Johnston et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Fischer et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Sipp et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Dos Remedios et al. | 1.0 | 1 | 1 | 20 | 0.25 | 0.00 | 1.00 | 5 | Durgin et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 |
Total | 7.0 | 5 | 3 | 140 | 0.25 | 0.00 | 1.67 | 35 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Minarik et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Berkeley | 1.0 | 4 | 1 | 20 | 1.75 | 0.00 | 4.00 | 35 | Johnston et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Fischer et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Sipp et al. | 1.0 | 2 | 1 | 20 | 0.75 | 0.00 | 2.00 | 15 | Dos Remedios et al. | 1.0 | 2 | 1 | 20 | 0.75 | 0.00 | 2.00 | 15 | Durgin et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 |
Total | 7.0 | 13 | 3 | 140 | 0.82 | 0.00 | 4.33 | 115 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Minarik et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Berkeley | 1.0 | 1 | 1 | 20 | 0.25 | 0.00 | 1.00 | 5 | Johnston et al. | 1.0 | 3 | 1 | 20 | 1.25 | 0.00 | 3.00 | 25 | Fischer et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Sipp et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Dos Remedios et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Durgin et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 |
Total | 7.0 | 7 | 2 | 140 | 0.43 | 0.00 | 3.50 | 60 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Minarik et al. | 1.0 | 5 | 0 | 20 | 2.50 | 0.00 | inf | 50 | Berkeley | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 | Johnston et al. | 1.0 | 4 | 0 | 20 | 2.00 | 0.00 | inf | 40 | Fischer et al. | 1.0 | 6 | 1 | 20 | 2.75 | 0.00 | 6.00 | 55 | Sipp et al. | 1.0 | 4 | 0 | 20 | 2.00 | 0.00 | inf | 40 | Dos Remedios et al. | 1.0 | 3 | 1 | 20 | 1.25 | 0.00 | 3.00 | 25 | Durgin et al. | 1.0 | 5 | 4 | 20 | 1.50 | 0.00 | 1.25 | 30 |
Total | 7.0 | 30 | 6 | 140 | 1.93 | 0.00 | 5.00 | 270 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Berkeley | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Minarik et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Caleb Kendrick is the new Batman | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Durgin et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Dos Remedios et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Sipp et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Fischer et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 |
Total | 7.0 | 4 | 0 | 140 | 0.29 | 0.00 | inf | 40 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Berkeley | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Minarik et al. | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 | Caleb Kendrick is the new Batman | 1.0 | 4 | 0 | 20 | 2.00 | 0.00 | inf | 40 | Durgin et al. | 1.0 | 2 | 1 | 20 | 0.75 | 0.00 | 2.00 | 15 | Dos Remedios et al. | 1.0 | 1 | 1 | 20 | 0.25 | 0.00 | 1.00 | 5 | Sipp et al. | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 | Fischer et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 |
Total | 7.0 | 17 | 2 | 140 | 1.14 | 0.00 | 8.50 | 160 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Berkeley | 1.0 | 4 | 0 | 20 | 2.00 | 0.00 | inf | 40 | Minarik et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Caleb Kendrick is the new Batman | 1.0 | 4 | 0 | 20 | 2.00 | 0.00 | inf | 40 | Durgin et al. | 1.0 | 6 | 1 | 20 | 2.75 | 0.00 | 6.00 | 55 | Dos Remedios et al. | 1.0 | 4 | 1 | 20 | 1.75 | 0.00 | 4.00 | 35 | Sipp et al. | 1.0 | 5 | 0 | 20 | 2.50 | 0.00 | inf | 50 | Fischer et al. | 1.0 | 6 | 0 | 20 | 3.00 | 0.00 | inf | 60 |
Total | 7.0 | 30 | 2 | 140 | 2.07 | 0.00 | 15.00 | 290 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Berkeley | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 | Minarik et al. | 1.0 | 4 | 1 | 20 | 1.75 | 0.00 | 4.00 | 35 | Caleb Kendrick is the new Batman | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 | Durgin et al. | 1.0 | 2 | 1 | 20 | 0.75 | 0.00 | 2.00 | 15 | Dos Remedios et al. | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 | Sipp et al. | 1.0 | 4 | 0 | 20 | 2.00 | 0.00 | inf | 40 | Fischer et al. | 1.0 | 4 | 0 | 20 | 2.00 | 0.00 | inf | 40 |
Total | 7.0 | 23 | 2 | 140 | 1.57 | 0.00 | 11.50 | 220 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Johnston et al. | 1.0 | 6 | 2 | 20 | 2.50 | 0.00 | 3.00 | 50 | Minarik et al. | 1.0 | 3 | 2 | 20 | 1.00 | 0.00 | 1.50 | 20 | Caleb Kendrick is the new Batman | 1.0 | 5 | 0 | 20 | 2.50 | 0.00 | inf | 50 | Sipp et al. | 1.0 | 4 | 0 | 20 | 2.00 | 0.00 | inf | 40 | Fischer et al. | 1.0 | 2 | 4 | 20 | 0.00 | 0.00 | 0.50 | 0 | Durgin et al. | 1.0 | 4 | 1 | 20 | 1.75 | 0.00 | 4.00 | 35 | Dos Remedios et al. | 1.0 | 2 | 3 | 20 | 0.25 | 0.00 | 0.67 | 5 |
Total | 7.0 | 26 | 12 | 140 | 1.43 | 0.00 | 2.17 | 200 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Johnston et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Minarik et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Caleb Kendrick is the new Batman | 1.0 | 5 | 1 | 20 | 2.25 | 0.00 | 5.00 | 45 | Sipp et al. | 1.0 | 3 | 1 | 20 | 1.25 | 0.00 | 3.00 | 25 | Fischer et al. | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 | Durgin et al. | 1.0 | 6 | 0 | 20 | 3.00 | 0.00 | inf | 60 | Dos Remedios et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 |
Total | 7.0 | 23 | 2 | 140 | 1.57 | 0.00 | 11.50 | 220 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Johnston et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Minarik et al. | 1.0 | 0 | 1 | 20 | -0.25 | 0.00 | 0.00 | -5 | Caleb Kendrick is the new Batman | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Sipp et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Fischer et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Durgin et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Dos Remedios et al. | 1.0 | 1 | 1 | 20 | 0.25 | 0.00 | 1.00 | 5 |
Total | 7.0 | 6 | 2 | 140 | 0.36 | 0.00 | 3.00 | 50 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Johnston et al. | 0.5 | 0 | 0 | 10 | 0.00 | 0.00 | 0.00 | 0 | Minarik et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Caleb Kendrick is the new Batman | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Sipp et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Fischer et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Durgin et al. | 1.0 | 1 | 2 | 20 | 0.00 | 0.00 | 0.50 | 0 | Dos Remedios et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 |
Total | 6.5 | 4 | 2 | 130 | 0.23 | 0.00 | 2.00 | 30 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Caleb Kendrick is the new Batman | 1.0 | 7 | 2 | 20 | 3.00 | 0.00 | 3.50 | 60 | Berkeley | 1.0 | 8 | 2 | 20 | 3.50 | 0.00 | 4.00 | 70 | Johnston et al. | 1.0 | 8 | 0 | 20 | 4.00 | 0.00 | inf | 80 | Dos Remedios et al. | 1.0 | 8 | 2 | 20 | 3.50 | 0.00 | 4.00 | 70 | Durgin et al. | 1.0 | 10 | 2 | 20 | 4.50 | 0.00 | 5.00 | 90 | Fischer et al. | 1.0 | 8 | 5 | 20 | 2.75 | 0.00 | 1.60 | 55 | Sipp et al. | 1.0 | 9 | 4 | 20 | 3.50 | 0.00 | 2.25 | 70 |
Total | 7.0 | 58 | 17 | 140 | 3.54 | 0.00 | 3.41 | 495 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Caleb Kendrick is the new Batman | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Berkeley | 1.0 | 5 | 3 | 20 | 1.75 | 0.00 | 1.67 | 35 | Johnston et al. | 1.0 | 2 | 3 | 20 | 0.25 | 0.00 | 0.67 | 5 | Dos Remedios et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Durgin et al. | 1.0 | 4 | 1 | 20 | 1.75 | 0.00 | 4.00 | 35 | Fischer et al. | 0.5 | 2 | 0 | 10 | 2.00 | 0.00 | inf | 20 |
Total | 5.5 | 15 | 7 | 110 | 1.05 | 0.00 | 2.14 | 115 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Caleb Kendrick is the new Batman | 1.0 | 4 | 1 | 20 | 1.75 | 0.00 | 4.00 | 35 | Berkeley | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Johnston et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Dos Remedios et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Durgin et al. | 1.0 | 1 | 1 | 20 | 0.25 | 0.00 | 1.00 | 5 | Fischer et al. | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Sipp et al. | 1.0 | 4 | 0 | 20 | 2.00 | 0.00 | inf | 40 |
Total | 7.0 | 10 | 2 | 140 | 0.64 | 0.00 | 5.00 | 90 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Bentley et al. | 1.0 | 2 | 0 | 20 | 1.00 | 0.00 | inf | 20 | Davis et al. | 1.0 | 2 | 1 | 20 | 0.75 | 0.00 | 2.00 | 15 | The Special Relationship | 1.0 | 1 | 1 | 20 | 0.25 | 0.00 | 1.00 | 5 | Rogue Squadron | 1.0 | 4 | 0 | 20 | 2.00 | 0.00 | inf | 40 | Libo-chan's Busse-ted Wang | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 | Byrnt Norton | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Nguyen et al. | 1.0 | 1 | 0 | 20 | 0.50 | 0.00 | inf | 10 |
Total | 7.0 | 11 | 2 | 140 | 0.71 | 0.00 | 5.50 | 100 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Bentley et al. | 1.0 | 5 | 0 | 20 | 2.50 | 0.00 | inf | 50 | Davis et al. | 1.0 | 2 | 1 | 20 | 0.75 | 0.00 | 2.00 | 15 | The Special Relationship | 1.0 | 5 | 2 | 20 | 2.00 | 0.00 | 2.50 | 40 | Rogue Squadron | 1.0 | 4 | 0 | 20 | 2.00 | 0.00 | inf | 40 | Libo-chan's Busse-ted Wang | 1.0 | 4 | 0 | 20 | 2.00 | 0.00 | inf | 40 | Byrnt Norton | 1.0 | 3 | 1 | 20 | 1.25 | 0.00 | 3.00 | 25 | Nguyen et al. | 1.0 | 2 | 1 | 20 | 0.75 | 0.00 | 2.00 | 15 |
Total | 7.0 | 25 | 5 | 140 | 1.61 | 0.00 | 5.00 | 225 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Bentley et al. | 1.0 | 4 | 1 | 20 | 1.75 | 0.00 | 4.00 | 35 | Davis et al. | 1.0 | 1 | 1 | 20 | 0.25 | 0.00 | 1.00 | 5 | The Special Relationship | 1.0 | 2 | 1 | 20 | 0.75 | 0.00 | 2.00 | 15 | Rogue Squadron | 1.0 | 3 | 0 | 20 | 1.50 | 0.00 | inf | 30 | Libo-chan's Busse-ted Wang | 1.0 | 2 | 1 | 20 | 0.75 | 0.00 | 2.00 | 15 | Byrnt Norton | 1.0 | 5 | 1 | 20 | 2.25 | 0.00 | 5.00 | 45 | Nguyen et al. | 1.0 | 1 | 1 | 20 | 0.25 | 0.00 | 1.00 | 5 |
Total | 7.0 | 18 | 6 | 140 | 1.07 | 0.00 | 3.00 | 150 |
Opponent | GP | 10 | -5 | TUH | P/TU | P/N | G/N | Pts | Bentley et al. | 1.0 | 4 | 1 | 20 | 1.75 | 0.00 | 4.00 | 35 | Davis et al. | 1.0 | 5 | 1 | 20 | 2.25 | 0.00 | 5.00 | 45 | The Special Relationship | 1.0 | 0 | 0 | 20 | 0.00 | 0.00 | 0.00 | 0 | Rogue Squadron | 1.0 | 5 | 0 | 20 | 2.50 | 0.00 | inf | 50 | Libo-chan's Busse-ted Wang | 1.0 | 5 | 2 | 20 | 2.00 | 0.00 | 2.50 | 40 | Byrnt Norton | 1.0 | 4 | 2 | 20 | 1.50 | 0.00 | 2.00 | 30 | Nguyen et al. | 1.0 | 3 | 1 | 20 | 1.25 | 0.00 | 3.00 | 25 |
Total | 7.0 | 26 | 7 | 140 | 1.61 | 0.00 | 3.71 | 225 |